Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt. Ives PLC Regulatory News (SIV)

  • There is currently no data for SIV

Intended Listing Cancellation & Proposed Delisting

22 Jul 2025 07:00

RNS Number : 9444R
Sivota PLC
22 July 2025
 

22 July 2025

Sivota plc

Intended Cancellation of Listing and Proposed Delisting from the London Stock Exchange

 

Sivota plc ("Sivota" or the "Company"), the investment vehicle focused on acquiring and scaling technology-led businesses in Israel, announces its intention to cancel the admission of its ordinary shares ("Shares") to trading on the London Stock Exchange (the "Delisting").

 Background and Rationale for Delisting

 Since admission, Sivota has operated as a public company with the aim of deploying growth capital into high-potential businesses and delivering shareholder value through strategic investment and operational support.

However, after extensive review and consideration, the Board has concluded that the Company's continued listing is no longer in the best interests of the business or its shareholders, for the following key reasons:

1. Increased Difficulty in Raising Capital from Public Markets:

The Company has found it increasingly challenging to raise meaningful investment capital via the public markets. Low liquidity, limited institutional appetite, and broader market conditions have constrained the Company's ability pursue new investment opportunities at the pace originally envisaged.

2. Material Changes in the Geopolitical and Economic Environment:

The geopolitical landscape and macroeconomic conditions have changed significantly since the Company's investment strategy was formulated and its original listing. These shifts have increased uncertainty and altered the operational dynamics within Sivota's target market.

As a company listed on the Equity Shares (Transition) category, the Company is not required to obtain the approval of its shareholders for the Delisting but is required under UK Listing Rule 21.2.17 to give at least 20 business days' notice of the intended cancellation.

Accordingly, the Company has requested that: (i) the FCA cancel the listing of the Shares on the Official List of the FCA; and (ii) the London Stock Exchange cancels the admission to trading of the Shares on the Main Market for listed securities of the London Stock Exchange.

It is anticipated that the Delisting will become effective from 8:00 a.m. (London time) on 19 August 2025. Investors holding Shares following the Delisting will remain shareholders of the Company and continue to be entitled to exercise all the rights attaching to the Shares.

The principal effects of the Delisting will be that:

· there will no longer be a formal market mechanism enabling shareholders to trade their Ordinary Shares;

· the regulatory and financial reporting regime applicable to companies whose shares are admitted to trading on the London Stock Exchange will no longer apply;

· shareholders will no longer be afforded the protections given by the UK Listing Rules, such as the requirement to be notified of certain material developments or events (including substantial transactions, financing transactions, related party transactions and certain acquisitions and disposals) and the separate requirement to seek shareholder approval for certain other corporate events such as reverse takeovers or fundamental changes in the Company's business;

· shareholders will no longer be required to publicly disclose any change in major shareholdings in the Company under the DTRs;

· the Company will no longer be subject to the provisions of the Market Abuse Regulation (as in force in the United Kingdom) regulating inside information and other matters, which will make it easier for the Company to keep shareholders up to date on any developments; and

The Company will, at least in the short term, remain a public limited company (and so, for example, will be required to hold an AGM in each year). The provisions of the Takeover Code will continue to apply to the Company.

Further Information

The Company will continue to keep shareholders informed and provide updates as appropriate.

 

Enquiries:

Sivota PLC

Tim Weller, Non-Executive Chairman

www.sivotacapital.com

 

via Vigo Consulting

Canaccord Genuity Limited

Bobbie Hilliam

 

+44 (0) 20 7523 8000

Vigo Consulting

Jeremy Garcia

+ 44 (0) 20 7390 0230

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCRBMFTMTATBTA
Date   Source Headline
22nd Jul 20257:00 amRNSIntended Listing Cancellation & Proposed Delisting
25th Jun 202510:00 amRNSResult of AGM
30th Apr 20257:00 amRNSFinal Results
5th Mar 20257:00 amRNSPotential Placing to raise c.£250,000
30th Aug 20249:00 amRNSHalf-year Report
9th Jul 20247:00 amRNSApester's bankruptcy
27th Jun 202411:30 amRNSResults of Annual General Meeting
4th Jun 202411:00 amRNSNotice of General Meeting
17th May 20249:31 amRNSTermination of Transaction Negotiations
30th Apr 20241:02 pmRNSFinal Results
26th Jan 20249:00 amRNSAppointment of Auditor
12th Jan 20247:00 amRNSEntry into non-binding term sheet
27th Sep 20239:42 amRNSHalf Year Results
7th Sep 20232:16 pmRNSResults of General Meeting
15th Aug 20237:30 amRNSNotice of General Meeting
8th Aug 20237:00 amRNSAppointment of CEO at Sivota’s subsidiary, Apester
21st Jun 20236:26 pmRNSResult of Annual General Meeting
26th May 20237:00 amRNSNotice of 2023 Annual General Meeting
22nd May 202311:16 amRNSChange of Registered Office
28th Apr 20231:52 pmRNSFinal Results
11th Jan 20237:00 amRNSBusiness update
22nd Nov 20221:17 pmRNSHolding(s) in Company
15th Nov 20229:25 amRNSHolding(s) in Company
14th Nov 20222:34 pmRNSHolding(s) in Company
14th Nov 20222:33 pmRNSHolding(s) in Company
14th Nov 20222:32 pmRNSHolding(s) in Company
14th Nov 20222:31 pmRNSHolding(s) in Company
14th Nov 20222:30 pmRNSHolding(s) in Company
14th Nov 20222:29 pmRNSHolding(s) in Company
30th Sep 20227:00 amRNSHalf-year Results
26th Sep 20228:00 amRNSReadmission - Sivota plc
26th Sep 20227:10 amRNSAppointment of CEO at Sivota’s subsidiary, Apester
26th Sep 20227:00 amRNSReadmission
22nd Sep 20222:38 pmRNSReadmission and Publication of Prospectus
22nd Sep 20227:00 amRNSReadmission and Publication of Prospectus
30th Aug 20222:24 pmRNSResult of AGM
17th Aug 20225:42 pmRNSNotice of AGM
30th Jun 20227:00 amRNSFinal Results
13th May 20227:00 amRNSAcquisition of Majority Stake in Apester & Placing
22nd Feb 20227:00 amRNSResults of General Meeting
28th Jan 20227:00 amRNSPosting of Shareholder Circular and Notice of GM
25th Jan 20227:00 amRNSConditional Acquisition of Stake in Apester
7th Dec 20218:23 amRNSRTO Transaction and Suspension of Listing
27th Sep 20218:40 amRNSHalf-year Results
5th Aug 20219:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.